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Abstract
Background: The success of a clinical trial is often dependant on whether recruitment targets can be met in the
required time frame. Despite an increase in research into the benefits of exercise in people with multiple sclerosis
(PwMS), no trial has reported detailed data on effective recruitment strategies for large-scale randomised controlled
trials. The main purpose of this report is to provide a detailed outline of recruitment strategies, rates and estimated
costs in the Exercise Intervention for Multiple Sclerosis (ExIMS) trial to identify best practices for future trials involving
multiple sclerosis (MS) patient recruitment.
Methods: The ExIMS researchers recruited 120 PwMS to participate in a 12-week exercise intervention. Participants
were randomly allocated to either exercise or usual-care control groups. Participants were sedentary, aged 18–65 years
and had Expanded Disability Status Scale scores of 1.0–6.5. Recruitment strategies included attendance at MS outpatient
clinics, consultant mail-out and trial awareness-raising activities.
Results: A total of 120 participants were recruited over the course of 34 months. To achieve this target, 369 potentially
eligible and interested participants were identified. A total of 60 % of participants were recruited via MS clinics, 29.2 %
from consultant mail-outs and 10.8 % through trial awareness. The randomisation yields were 33.2 %, 31.0 % and 68.4 %
for MS clinic, consultant mail-outs and trial awareness strategies, respectively. The main reason for ineligibility was being
too active (69.2 %), whilst for eligible participants the most common reason for non-participation was the need to travel
to the study site (15.8 %). Recruitment via consultant mail-out was the most cost-effective strategy, with MS clinics being
the most time-consuming and most costly.
Conclusions: To reach recruitment targets in a timely fashion, a variety of methods were employed. Although consultant
mail-outs were the most cost-effective recruitment strategy, use of this method alone would not have allowed us to
obtain the predetermined number of participants in the required time period, thus leading to costly extensions of the
project or failure to reach the number of participants required for sufficient statistical power. Thus, a multifaceted
approach to recruitment is recommended for future trials.
Trial registration: International Standard Randomised Controlled Trial Registry number: ISRCTN41541516; date
registered: 5 February 2009.
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Background
One of the most difficult challenges in clinical trials is
whether appropriate participants can be identified and
consented quickly [1]. Many trials either fail to reach re-
cruitment targets or have to be extended [2]. This leads
to either an underpowered study or an extension of the
duration of the study, often at additional cost, impacting
the time required to inform clinical practice and using
funds that could have been used for other research
[3, 4]. The implementation of an efficient and effect-
ive recruitment strategy for patients in clinical trials
is critical if expensive delays and failure to meet pre-
determined targets are to be avoided [5].
The introduction of Consolidated Standards of Report-
ing Trials (CONSORT) guidelines [6] has improved the
quality of recruitment information reported for rando-
mised controlled trials (RCTs). However, detailed data
on recruitment, including methods used, rates achieved
and cost are still underreported. More detailed data
would help to identify strategies to improve recruitment,
benefiting both researchers and research [4] and ultim-
ately patients.
In recent years, there has been an increase in the
number of studies of the possible health benefits of
exercise for people with multiple sclerosis (PwMS)
[7–9]. Although detailed recruitment data for exercise
interventions in other clinical populations, such as
patients with breast cancer and wheelchair users, are
available [10–12], to date no study has reported re-
cruitment data for a large-scale RCT of exercise for
PwMS. In recent years, the number of clinical trials
in multiple sclerosis (MS) has increased, leading to an
increased need to recruit research participants from a
limited patient pool, and with modern trials often
needing large sample sizes to ensure adequate statis-
tical power [13].
The Exercise Intervention for Multiple Sclerosis
(ExIMS) trial was a large-scale RCT involving 120
people with mild to moderate MS. It was designed to
investigate the short- and longer-term health impacts
of a 12-week pragmatic exercise programme [14, 15].
The main purpose of this report is to provide a de-
tailed outline of the recruitment methods, rates and
estimated cost to help inform future research of this
type. In addition, we aim to determine which recruit-
ment method provided the highest yield of participants
and the lowest cost per participant.
Methods
Trial design
Only a brief description of the trial design is reported
here, as detailed protocol and outcomes papers for this
study have been published elsewhere [14–16]. Power cal-
culations indicated that we would need 100 PwMS to
complete the trial. This, alongside the retention rates ob-
served in our feasibility study of 87 % immediately fol-
lowing the intervention and 80 % at 3 months [17], led
to a recruitment target of 120 PwMS (60 in each group).
The project was funded for 3 years, and an initial re-
cruitment target of five participants per month over
24 months was set, with recruitment beginning in February
2009. A sample of 120 PwMS with mild to moderate dis-
ability [Expanded Disability Status Scale (EDSS) score ≤6.5]
was recruited. Participants were randomized to a 12-week
pragmatic exercise intervention (2 × supervised and 1 ×
home-based session per week for 6 weeks, followed by
1 × supervised and 2 × home-based sessions per week
for 6 weeks, plus usual care) or usual care alone. The
primary outcome was self-reported exercise behaviour
at 3 months using the Godin Leisure Time Exercise
Questionnaire [18]. In addition, accelerometry was used
to provide an objective measure of daily activity and step
count (ActiGraph GT2M accelerometer; ActiGraph, Pen-
sacola, FL, USA). Secondary outcome measures included
fatigue, health-related quality of life, functional ability
and neurological impairment. Outcomes were assessed
at baseline, immediately postintervention (3 months)
and 6 months postintervention (9 months). This study
was approved by the South Yorkshire Research Ethics
Committee (08/H1310/69) according to the principles of
the Declaration of Helsinki, and all participants provided
informed consent before enrolment.
Eligibility criteria
Regardless of the recruitment method used, all partici-
pants were screened by a consultant neurologist before
entering the trial. Participants were included if they (1)
had a clinical diagnosis of MS based on the McDonald
diagnostic criteria for MS [19], (2) had an EDSS score
[20] between 1.0 and 6.5, (3) were between 18 and
65 years of age, (4) were stable on disease modifying
treatment for at least 3 months before recruitment, (5)
were clinically stable (had not experienced a relapse in
at least 4 weeks), (6) were physically able to participate
in exercise three times per week and (7) were able to
provide written informed consent. The exclusion criteria
were (1) failure to meet any of the inclusion criteria, (2)
experiencing illness that would be a contraindication to
exercise, (3) living farther than 20 miles from the trial
centre, (4) unwilling to be randomised to either group
and (5) already engaged in moderate structured exercise
at least three times per week for at least 30 minutes per
session consistently for the last 6 months. Participants
who were initially screened out either for having changed
their drug treatment in the last 3 months or for having had
a relapse in the previous 4 weeks were reassessed following
the required lapse of time and recruited if the eligibility cri-
teria were then met.
Carter et al. Trials  (2015) 16:468 Page 2 of 8
Recruitment methods
Participants were recruited continuously until the re-
quired sample size was obtained. All recruitment me-
thods and procedures were approved by the South
Yorkshire Research Ethics Committee. Regardless of
recruitment method, we adhered to the following proce-
dures (Table 1).
Consultant referral at MS outpatient clinic
Consultant referral at MS outpatient clinics was the pri-
mary recruitment strategy, as consultant recommenda-
tions are thought to play a crucial role in participants’
decisions to enrol in a clinical trial [1]. In addition, re-
cruitment by this method would reduce the possibility of
contacting patients who did not meet the eligibility
criteria.
MS outpatient clinics took place at the Royal Hallamshire
Hospital, Sheffield, UK, on a weekly basis. The project’s lead
consultant (BS) and two other neurology consultants
assisted with identifying potentially eligible and inter-
ested participants. Each consultant saw approximately
13 patients per clinic (10 follow-ups and 3 new pa-
tients) over a 3.5-h period. A trial researcher attended
all clinics, enabling any participants identified to speak
with them about the trial, ask any questions and confirm
eligibility. If interested, participants were booked in for a
familiarisation session at the trial site.
Consultant mail-out
To maintain a consistent flow of patients into the study,
participant mail-outs were timed to take place during
periods of low recruitment. Letters were sent in batches
of no more than 125 to manage the flow of patients into
the study and ensure that all participants who responded
could be contacted in a timely manner. All mail-outs
were personalised and sent by the project’s lead consult-
ant (BS) and contained the logos of the hospital, the uni-
versity and the funding body (MS Society). The details
of the participants to be included in the mail-outs were
obtained from the local MS risk-sharing scheme data-
base and clinic waiting lists. Notes of potential partici-
pants were screened for all available eligibility criteria
(clinical diagnosis of MS, distance from trial centre,
EDSS score and age). In addition, those who had been
contacted previously about the project through other
means and stated that they did not wish to take part
were screened out at this stage. Letters contained a reply
slip and a stamped, addressed envelope and the partici-
pant information sheet, along with a contact number for
further information. The trial manager contacted all in-
terested participants upon receipt of the reply slip to an-
swer any questions and confirm eligibility. No attempt
was made to contact patients who did not respond to
the invitation letter from their consultant.
Trial awareness strategies
Other trial awareness strategies included leaflets and
posters at clinics, therapy centres and regional MS so-
cieties, presentations and attendance at regional MS
Society events and to local MS physiotherapy teams,
referral from other professionals such as MS nurses
and word of mouth. Despite being reported as a po-
tentially successful recruitment method [10], we chose
not to use local media (radio, television and newspa-
pers), as it was felt that this might attract too many
individuals who would not meet the study eligibility
criteria. It was agreed that this strategy would be used
only as a last resort.
Incentives
Participants were reimbursed for travel costs (40 p/mile
up to a maximum of £10/visit) for all visits to the trial
centre, with free parking made available. Those more se-
verely disabled were also offered the option of using a
taxi service if other methods of transport would restrict
their ability to participate. Flexible appointment times
and start dates were made available to help participants
fit the trial commitments around work, child care and
fatigue patterns. To encourage participation, the usual-
care group was offered up to four exercise sessions fol-
lowing the study. This option was taken up by 20 % of
the usual-care participants who completed the study.
Data analysis
Participant recruitment rates were calculated as the
average number of participants recruited per month over
the duration of the recruitment period. Response rates
were reported as percentage interested and percentage
recruited. Recruitment yields were calculated as total re-
cruited divided by the number of interested participants.
Recruitment time was estimated on the basis of time
taken to ascertain interest and eligibility in the study and
Table 1 Recruitment process for Exercise Intervention for
Multiple Sclerosis trial
Recruitment process
• Potentially eligible participants identified (consultant neurologist,
mail-out, other)
• Trial manager made aware of participants interest
• Trial manager speaks (by telephone or in person) with participant
to outline study, answer questions and screen participants for all
eligibility criteria
• If interested and eligible, participant booked in for trial
familiarisation session (by telephone or in person)
• Potential participant attends trial familiarisation at trial site and
is given 7 days to consider participation
• Participant booked in for initial appointment to provide informed
consent and participate in baseline assessment
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did not include any other time taken to carry out famil-
iarisation visits and consent, as this was the same for all
recruitment methods. The time cost of each method was
calculated per participant recruited, based on the average
salary cost per hour of the trial researcher.
Results
A total of 349 potentially eligible participants were iden-
tified via the recruitment methods (217 MS clinic, 113
consultant mail-out and 19 trial awareness) (see Fig. 1).
For CONSORT checklist and flow diagram please see
Additional file 1.
Recruitment rates
The original recruitment period was planned to take
place over the course of 24 months. This was extended
to a period of 34 months (February 2009 to November
2011), owing to a lower than expected recruitment rate
of 3.5 ± 0.32 [mean ± 95 % confidence interval (CI)] partic-
ipants per month (see Fig. 2). Recruitment was carried out
by attending MS clinics and using trial awareness
strategies throughout this period. Mail-outs were con-
ducted in the second year of the trial at time points where
lower levels of recruitment from the clinic were observed
in the trial’s first year (July, August, February and October).
Response rates
Of approximately 3393 people with MS who attended
the MS outpatient clinic during the recruitment period,
217 (6.4 %) were identified as potentially interested and
eligible. Of these 217, 23 (10.6 %) were ineligible and
122 (56.2 %) declined to participate.
Mail-outs were sent to 311 potentially eligible partici-
pants. Of these candidates, 133 (42.8 %) PwMS expressed
Fig. 1 Flow diagram of participant recruitment to the Exercise Intervention for Multiple Sclerosis (ExIMS) trial. DMT disease-modifying therapy MS
multiple sclerosis
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an interest in the trial, 15 (11.2 %) of whom were ineligible
and 63 (47.3 %) of whom declined to participate.
Our trial awareness strategies provided 19 interested
individuals from among an unknown pool of potential
participants, one (5 %) of whom was ineligible and four
(21.1 %) of whom declined to participate.
Randomisation yields/accrual rates
The randomisation yield was 33.2 % (72 of 217) from
the MS clinic, 31.0 % (35 of 113) for consultant mail-
outs and 68.4 % (13 of 19) for those contacted via trial
awareness strategies. This led to 60 % (72 of 120) of par-
ticipants being recruited via MS clinics, 29.2 % (35 of
120) via mail-outs and 10.8 % (13 of 120) via trial aware-
ness strategies.
Reasons for ineligibility
A total of 39 participants (23 MS clinic, 15 mail-out and
1 trial awareness) who had expressed an interest were
ineligible. In order of prevalence, the main reasons for
ineligibility were too active (27 of 39; 69.2 %), recent
change in disease-modifying therapy (4 of 39; 10.3 %),
recent MS relapse (3 of 39; 7.7 %), participating in an-
other trial (2 of 39; 5.1 %), no definitive diagnosis of MS
(2 of 39; 5.1 %) and too old (1 of 39; 2.6 %).
Reasons for declining participation
The reasons that eligible participants declined to partici-
pate, in order of prevalence, were no reason given (126
of 190; 66.3 %), issues with transport/travel to the trial
site (30 of 190; 15.8 %), other commitments (23 of 190;
12.1 %), negative perceptions of exercise (10 of 190;
5.3 %) and loss of benefit worries (1 of 190; 0.5 %).
Recruitment time/cost
MS clinics required the longest recruitment time of
4.2 h per participant, whilst the consultant mail-out had
the shortest recruitment time of 0.6 h per participant
(see Table 2).
Discussion
Recruitment rates
Recruitment into this study was slower than anticipated
at 3.5 ± 0.32 (mean ± 95 % CI) participants per month,
leading to the trial’s failing to recruit on time and an ex-
tended recruitment period of 34 months (from an initial
target of 24 months) needed to reach the target number
of participants. Recruitment rates have not been re-
ported previously for large-scale exercise trials in PwMS,
but investigators who studied a non-exercise interven-
tion using computerised cognitive behavioural therapy
for PwMS reported slightly lower rates of 2.6/month
[21]. Researchers in a multicentre RCT for a group-
based fatigue management programme reported recruit-
ment of 13.0 participants per month (across 3 sites),
equating to 4.3 per trial site [22]. However, both these
trials had a lower patient time commitment than ExIMS.
Investigators in exercise trials with other clinical groups
have reported similar recruitment rates, such as wheel-
chair users (2.9/month) [11], breast cancer survivors (3.8/
month) [10] and elderly stroke survivors (4.0/month) [23].
This suggests that our observed recruitment rate of 3.5
participants per month is a realistic target for future
Fig. 2 Predicted and actual recruitment rates for participants in the Exercise Intervention for Multiple Sclerosis research trial. PwMS people with
multiple sclerosis
Carter et al. Trials  (2015) 16:468 Page 5 of 8
RCTs involving exercise for PwMS that require regu-
lar attendance.
Response rates
The response rate from a potentially large pool of partic-
ipants at MS clinics was low at 6.4 %. The reasons for
this may be related to patients being ineligible (changing
to new medication, experiencing a relapse, new patient,
other neurological condition), consultants too busy to
recruit during clinic time and/or patients disinterested
in the study. As might be expected, response rates to
personalised consultant study invitation letters were
higher (42.8 %), as this strategy was targeted much more
towards eligible individuals. However, this still leaves
nearly 60 % of potential participants who did not re-
spond to the invitation. As suggested by Daley et al.
[10], it is possible that non-responders were either de-
terred by the demanding nature of exercise trials or were
already engaged in regular physical activity. The latter
seems less likely, owing to the lower physical activity
rates reported in PwMS [24].
Randomisation yields/accrual rates
The trial recruited 60 % of the 120 participants from the
MS outpatient clinic, with 29.2 % recruited via consult-
ant mail-out and 10.8 % via trial awareness strategies.
However, the randomisation yield (number recruited/
number interested) was similar for both the MS clinic
and consultant mail-outs (33.2 % and 31.0 %, respect-
ively), suggesting that both methods are useful in attain-
ing recruitment targets. Values reported in the exercise
literature are varied, with an exercise trial for wheelchair
users reporting a randomisation yield of 41.8 % [11] and
an exercise trial with breast cancer survivors reporting
yields of 13.3 % from consultant letters and 29.7 % from
community strategies. In addition, a cognitive behav-
ioural trial for PwMS had relatively low yields of 4.5 %
for the MS clinic and 4.0 % from mail-outs [21]. Hence,
our data suggest that PwMS are as interested as other
clinical populations in participating in a supervised
exercise trial and may be more interested in an exer-
cise trial than other behavioural interventions with
similar time constraints.
Reasons for ineligibility
There were a number of reasons why people interested
in the trial were ineligible to take part. The most com-
mon reason for ineligibility was already being too active
to participate (69.2 %) owing to already being engaged in
moderate structured exercise at least three times per
week for at least 30 minutes per session consistently for
the last 6 months. This is consistent with reasons for
non-eligibility reported in a similar exercise intervention
with breast cancer survivors in which 55 % of those in-
terested were ineligible owing to already being too active
[10]. The number of potential participants screened out
for already being too active was much less (8.5 %) in a
group of wheelchair users [11], suggesting that physical
disability may impact heavily on current exercise levels.
Our data suggest that despite the physical disabilities of
MS, there are many people with mild to moderate levels
of disability due to the condition who are managing to
participate in moderate-intensity exercise over a pro-
longed period. However, data from the wheelchair exer-
cise study [11] would suggest that PwMS who have
higher levels of disability may be less physically active.
Reasons for choosing not to participate
The reasons that eligible participants have given for
choosing not to take part in exercise intervention studies
have rarely been reported, but they can offer valuable
insight into areas of trial design that may be improved
to enhance recruitment. Many PwMS (66.3 %) did not
specify why they had declined to take part. However, of
those who did, the need to travel to the trial site,
negative perceptions of exercise and loss of benefit
worries were all factors that could potentially be over-
come in future trials through design modifications
and patient education.
Table 2 Estimated time to identify and recruit participants and the associated costs
Recruitment method Time spent recruiting
(h)
Time per potential participant
(h)a
Time per recruited participant
(h)b
Cost per recruit
(based on estimated cost
of a researcher £25/h)
MS outpatient clinic 304.5 (87 clinics) 1.4 (304.5/217) 4.2 (304.5/72) £105 (£25 × 4.2)
Consultant mail-out 20 (5 mail-outs) 0.2 (20/113) 0.6 (20/35) £15 (£25 × 0.6)
Trial awareness
strategies
26c 1.5 (29/19) 2.2 (29/13) £55 (£25 × 2.2)
All strategies 350.5 1.4 (350.5/349) 2.9 (350.5/120) £72.50 (£25 × 2.9)
MS multiple sclerosis
aTime per recruited participant (h) is calculated as time spent recruiting/number of participants recruited
bAn estimated 26 h were spent raising awareness of the trial, which included producing a flyer and attending and giving talks at various MS events
cTime per potential participant (h) is calculated as time spent recruiting (h)/number of potentially eligible participants
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Recruitment time/cost
Recruitment is a time-consuming process, with resear-
chers in some community-based trials reporting up to
10 h per participant to recruit [25]. The present study
average was 2.9 h per participant. Study mail-outs were
reported to be the most efficient recruitment method at
only 0.6 h per participant. However, only 29.2 % of the
study’s overall cohort recruited by this method, suggest-
ing the importance of the more time-consuming method
of recruitment through MS outpatient clinics. Although
this method required 4.2 h per participant, it yielded
60 % of the study’s total cohort. In the present study,
costs were based on a researcher doing all the re-
cruitment, regardless of method; however, if recruit-
ment at the clinic had incurred additional consultant
time, costs for this method would have been much
higher.
Limitations
There was the potential for cross-contamination across
recruitment pathways, as participants may have been
reached by more than one method. For example, PwMS
may have seen trial awareness information before at-
tending an appointment at the MS clinic, which may
have made them more likely to be recruit by this
method. This could be improved in future studies by
asking participants if they have been made aware of the
study by any other means. In addition, it was not a re-
quirement of the study for individuals to provide reasons
for declining to take part in the study. It would be useful
to include methods for collecting these data so that
strategies could be developed to increase recruitment
yield and hence decrease recruitment costs.
Conclusions
Achievement of predetermined recruitment targets is a
critical factor influencing the success of RCTs. Well-
designed feasibility work and a combination of recruit-
ment methods can help to ensure that a trial is appropri-
ately designed to reach targets. Although consultant
mail-outs were shown to be the most cost-effective re-
cruitment strategy, this method alone may well be insuf-
ficient to meet recruitment targets in time-limited RCTs.
In this study, we report, for the first time to our know-
ledge, the pros and cons of different recruitment
methods in RCTs involving exercise for PwMS. On the
basis of our results, we recommend a combination of
methods to meet recruitment targets. The results pro-
vide novel insights into challenges of trial recruitment in
this context and can be used to inform the design of fu-
ture trials in this population; recruitment for other types
of trials, such as drug trials, may be different.
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